Clinical Trials in Miami

Showing 11301-11320 of 11,431 trials

Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice

NCT00301340

Summers Laboratories has developed a non-pesticide treatment for head lice. Lice Asphyxiator (L.A.) works by mechanically blocking the respiratory spiracles of the head lice, therefore causing a quick-acting suffocation that will not result in the development of resistance. The objectives of this open label study are to evaluate the efficacy and safety of home use of two 10-minute treatments of 5% L.A. (applied one week apart).

Head Lice

Summers Laboratories200 participantsStarted Mar 2006

Miami, Florida, United States • Council Bluffs, Iowa, United States • Cincinnati, Ohio, United States +2 more locations

COMPLETEDPhase 4< 1 mile

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

NCT00327691

The primary objective of this study is to determine the degree of additional reduction in cardiovascular risk that was accrued to patients by lowering their LDL-C beyond the currently accepted minimum target level for patients with pre-existing CHD. Secondary objectives include the safety profile of this treatment strategy, its cost-effectiveness, effect on other atherosclerotic-related events and procedures, and total mortality.

Cardiovascular DiseaseCerebrovascular AccidentCoronary Heart Disease

Pfizer8,600 participantsStarted Apr 1998

Alabaster, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +311 more locations

Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Find Trials by Condition in Miami

Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects

Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery

Buprenorphine and Integrated HIV Care Evaluation

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

Urge Incontinence Bladder Overactivity Study

Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia